DaVita (DVA), Nuwellis Extend Pilot Collaboration for Aquadex
https://www.zacks.com/stock/news/2286095/davita-dva-nuwellis-extend-pilot-collaboration-for-aquadex?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2286095
Jun 10, 2024 - DaVita (DVA) extends its pilot collaboration with Nuwellis to conduct additional testing of the Aquadex ultrafiltration treatment for adult patients suffering from congestive heart failure and related conditions.
0
Intuitive Surgical (ISRG) Gets FDA Nod for da Vinci's New Label
https://www.zacks.com/stock/news/2285583/intuitive-surgical-isrg-gets-fda-nod-for-da-vinci-s-new-label?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2285583
Jun 07, 2024 - Intuitive Surgical (ISRG) announces the FDA clearance of revised da Vinci Xi and X Labeling on Radical Prostatectomy.
0
Reasons to Retain Fresenius Medical (FMS) in Your Portfolio Now
https://www.zacks.com/stock/news/2285553/reasons-to-retain-fresenius-medical-fms-in-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2285553
Jun 07, 2024 - Fresenius Medical (FMS) continues to gain traction through its broad dialysis product and service portfolio. Intense competition is a woe.
0
Reasons to Add Masimo (MASI) Stock to Your Portfolio Now
https://www.zacks.com/stock/news/2285554/reasons-to-add-masimo-masi-stock-to-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2285554
Jun 07, 2024 - Masimo's (MASI) R&D activities raise optimism about the stock.
0
What Makes L.B. Foster (FSTR) Stock a Solid Choice Right Now
https://www.zacks.com/stock/news/2284941/what-makes-l-b-foster-fstr-stock-a-solid-choice-right-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2284941
Jun 06, 2024 - L.B. Foster (FSTR) offers a strong investment opportunity with stellar first-quarter earnings, promising growth prospects and solid operational performance set to continue through 2024.
0
Air Liquide (AIQUY) to Build Gas Facility for Chip Production
https://www.zacks.com/stock/news/2284935/air-liquide-aiquy-to-build-gas-facility-for-chip-production?cid=CS-ZC-FT-analyst_blog|company_news_corporate_actions-2284935
Jun 06, 2024 - Air Liquide (AIQUY) is investing $250 million in an Idaho gas facility to support Micron Technology's new semiconductor fab, enhancing U.S. supply chain resilience.
0
DexCom's (DXCM) G7 CGM System Now Connects to Apple Watch
https://www.zacks.com/stock/news/2284728/dexcom-s-dxcm-g7-cgm-system-now-connects-to-apple-watch?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2284728
Jun 06, 2024 - DexCom (DXCM) announces the direct connectivity of its G7 CGM system to Apple Watch for users in the United States, the UK, and Ireland.
0
ArcelorMittal (MT) & Materialise Partner for Metal 3D Printing
https://www.zacks.com/stock/news/2284006/arcelormittal-mt-materialise-partner-for-metal-3d-printing?cid=CS-ZC-FT-analyst_blog|company_news_corporate_actions-2284006
Jun 05, 2024 - ArcelorMittal (MT) and Materialise join forces to enhance LPBF and metal 3D printing using advanced build processors and specialized steel powders.
0
DexCom (DXCM) Declines on Potential Competition for Stelo (revised)
https://www.zacks.com/stock/news/2283556/dexcom-dxcm-declines-on-potential-competition-for-stelo-revised?cid=CS-ZC-FT-analyst_blog|price_surge_/_plunge-2283556
Jun 04, 2024 - DexCom (DXCM) stock declined on Monday following the FDA approval of another over-the-counter glucose monitor, potentially fueling competition for Stelo.
0
Here's Why You Should Retain Nevro (NVRO) Stock for Now
https://www.zacks.com/stock/news/2283541/here-s-why-you-should-retain-nevro-nvro-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2283541
Jun 04, 2024 - Strength in Nevro's (NVRO) Senza Platform raises optimism about the stock.
0